SC 13G: Biofrontera Inc.

AI Summary

SC 13G filing by Biofrontera Inc..

Risk Assessment

Risk Level: low

Key Financial Figures

• $0.001 — me of Issuer) Common Stock, par value $0.001 (Title of Class of Securities) 0907

Filing Documents

• sc13g.htm (SC 13G) — 73KB
• 0001099910-24-000316.txt ( ) — 74KB

(b)

Item 1(b). Address of Issuer’s Principal Executive Offices: 120 Presidential Way, Suite 330, Woburn, MA 01801

(a)

Item 2(a). Name of Person Filing: Nabil Saad

(b)

Item 2(b). Address of Principal Business Office, or if None, Residence: 608-25 St Mary St. Toronto, ON, Canada M4Y 1R2

(c)

Item 2(c). Citizenship: Canada

(d)

Item 2(d). Title of Class of Securities: Common Stock, par value $0.001

(e)

Item 2(e). CUSIP Number: 09077D209 Item 3. If this statement is filed pursuant to Sections 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: (a) [ ] Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o). (b) [ ] Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c). (c) [ ] Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c). (d) [ ] Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8). (e) [ ] An investment adviser in accordance with Section 240.13d-1(b)(1) (ii)(E); (f) [ ] An employee benefit plan or endowment fund in accordance with Section 240.13d-1(b)(1)(ii)(F); (g) [ ] A parent holding company or control person in accordance with Section 240.13d-1(b)(1)(ii)(G); (h) [ ] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) [ ] A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) [ ] A non-U.S. institution in accordance with § 240.13d–1(b)(1)(ii)(J); (k) [ ] Group, in accordance with Section 240.13d-1(b)(1)(ii)(K). CUSIP No. 09077D209 13G Page 4 of 5 Pages Item 4. Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. (a) Amount beneficially owned: The shares of Common Stock beneficially owned by the reporting person consist of 337,822 shares of Common Stock. (b) Percent of class: 6.09%. The percentages reported in this Schedule 13G are based upon 5,543,518 shares of Common Stock outstanding as of August 12, 2024 as reported by the issuer on 10-Q filed on August 14, 2024. (c) Number of shares as to which such person has: (i) Sole power to vote or to direct the vote 337,822 (ii) Shared power to vote

View Full Filing

View this SC 13G filing on SEC EDGAR